NUCLEOLIN and breast carcinoma: We first confirmed that the AS1411 nucleolin aptamer used in our study17 conjugated to a TAP siRNA (Supplementary Fig. 1a) accumulated preferentially in the subcutaneously growing 4T1 breast carcinoma tumors (Supplementary Fig. 1b).